Kickstart Your 2025 ADC Development at the 4th World ADC Asia Summit
4차 Word ADC Asia 소개
第四届世界ADC亚洲峰会
第4回 世界ADCアジアサミット
Linking the East to the West in the ADC World
Following Isen's groundbreaking $1B+ ADC deal with China-based Foreseen Biotechnology, the rapid rise of new companies, billions of dollars in investments, and a surge in partnerships involving Asian firms continue to capture the world’s attention. All eyes are now focused on the clinical validation of the next big leap in ADC technologies.
In response to this momentum, the 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community. This summit brings together cutting-edge innovators from Asia and the expertise of the West to chart a path to ADC success across the region.
This year, we’re introducing 3 dynamic tracks covering discovery, preclinical, clinical, and CMC, alongside exclusive seminar days focusing on ADC fundamentals and Bispecific ADCs. Whether you're just starting out or a seasoned expert, the program offers something for professionals at every level.
Don’t miss this opportunity to gain a complete view of the ADC landscape in Asia. You’ll have access to insightful sessions on novel design trends, emerging clinical data, and strategic partnering and licensing decisions. Plus, connect with over 60+ industry-leading speakers from top companies such as AstraZeneca, Daiichi Sankyo, leading Asian ADC biotechs, innovative start-ups, and top-tier ADC service providers from around the globe.
What’s New for 2025?
2025년의 새로운 점은 무엇인가요?
2025年有什么新变化？
2025年の新しい内容は何ですか？
A Bispecific ADC Seminar Day
Bispecific ADCs (BsADCs) are revolutionizing cancer treatment, with Asia-based developers at the forefront. Join this session to explore BsADC target selection, design, and clinical translation, unlocking better target specificity and enhanced payload internalization.
A Discovery
Track
Asia is recognized as a leader in ADC discovery, with novel technologies continuously emerging. Join our discovery track to spotlight the latest innovations, including new targets, linkers, and payloads, and explore the benefits of each approach.
A Preclinical & Clinical Development Track
Asia has seen a surge in ADC asset development, and now, as the industry grows, the focus shifts to achieving clinical validation. Join our preclinical & clinical development track to hear the latest clinical readouts and bridge the gap from concept to clinic
CMC Track
Given the complexity of ADCs, ensuring high standards in CMC functions—such as process development, analytical development, quality control, and scale-up manufacturing—is both challenging and crucial. Join our CMC track to make ADC manufacturing faster, more cost-effective, and of higher quality
Introduction to ADCs Seminar Day
New to the ADC field? Get up to speed before the scientific program. This seminar will provide insights from years of research and lessons learned from failed clinical trials, leading to the approved ADCs and current innovations. Led by experts, this one-stop session will establish a solid understanding of the key elements in ADC discovery and early development.
Our World-Class Speaker Faculty Includes:
2025 년 전문 연사 발표
2025 专家演讲人
2025 専門家の演者
About World ADC Series
Word ADC 시리즈 소개
关于世界 ADC 系列
ワールドADCシリーズ紹介
The World ADC team ploughs its collective energy in to sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.
The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavours more informed and more robust.
We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.
Join us at the heart of the ADC community to improve your programmes and be part of the mission to develop better antibody drug conjugate drugs.
2025 Partnerships
파트너십 체결
合作伙伴
パートナー
Lead Partner
Senior Partners
Program Partner
Exhibition Partners
Branding Partner
See Why Your Peers Attended
동료들이 참석하고 싶어하는 이유를 확인하세요
查看为何您的同事们都想参与
なぜ同僚たちが参加したがるのか、確認してみてください
